|
Line |
Assets Current Year |
Nonadmitted Assets Current Year |
Net Admitted Assets Current Year |
Net Admitted Assets Prior Year |
| 01 |
Bonds |
500,670,903 |
0 |
500,670,903 |
540,680,798 |
| 02.1 |
Preferred stocks (stocks) |
0 |
0 |
0 |
0 |
| 02.2 |
Common stocks (stocks) |
147,948,424 |
0 |
147,948,424 |
117,684,963 |
| 03.1 |
First liens - mortgage loans on real estate |
0 |
0 |
0 |
0 |
| 03.2 |
Other than first liens - mortgage loans on real
estate |
0 |
0 |
0 |
0 |
| 04.1 |
Properties occupied by the company (less $0
encumbrances) (real estate) |
28,780,000 |
0 |
28,780,000 |
28,198,999 |
| 04.2 |
Properties held for the production of income (less
$0 encumbrances) (real estate) |
4,683,798 |
0 |
4,683,798 |
5,137,342 |
| 04.3 |
Properties held for sale (less $0 encumbrances)
(real estate) |
0 |
0 |
0 |
0 |
| 05 |
Cash $-35675677, cash equivalents $0 and short-term
investments $70787671 |
35,111,994 |
0 |
35,111,994 |
25,441,944 |
| 06 |
Contract loans (including $0 premium notes) |
0 |
0 |
0 |
0 |
| 07 |
Derivatives |
0 |
0 |
0 |
0 |
| 08 |
Other invested assets |
0 |
0 |
0 |
0 |
| 09 |
Receivables for securities |
0 |
0 |
0 |
1,289 |
| 10 |
Securities lending reinvested collateral assets |
0 |
0 |
0 |
0 |
| 11 |
Aggregate write-ins for invested assets |
14,452,586 |
11,609,062 |
2,843,524 |
3,335,999 |
| 12 |
Subtotals, cash and invested assets |
731,647,705 |
11,609,062 |
720,038,643 |
720,481,334 |
| 13 |
Title plants less $0 charged off (for Title insurers
only) |
0 |
0 |
0 |
0 |
| 14 |
Investment income due and accrued |
3,734,191 |
0 |
3,734,191 |
4,246,670 |
| 15.1 |
Uncollected premiums and agents' balances in the
course of collection (premiums and considerations) |
9,938,119 |
317,069 |
9,621,050 |
9,405,869 |
| 15.2 |
Deferred premiums, agents' balances and installments
booked but deferred and not yet due (including $0 earned but
unbilled premiums) (premiums and considerations) |
0 |
0 |
0 |
0 |
| 15.3 |
Accrued retrospective premiums (premiums and
considerations) |
0 |
0 |
0 |
0 |
| 16.1 |
Amounts recoverable from reinsurers (reinsurance) |
0 |
0 |
0 |
214,646 |
| 16.2 |
Funds held by or deposited with reinsured companies
(reinsurance) |
0 |
0 |
0 |
0 |
| 16.3 |
Other amounts receivable under reinsurance contracts
(reinsurance) |
0 |
0 |
0 |
0 |
| 17 |
Amounts receivable relating to uninsured plans |
29,640,919 |
1,005,385 |
28,635,534 |
38,081,683 |
| 18.1 |
Current federal and foreign income tax recoverable
and interest thereon |
0 |
0 |
0 |
0 |
| 18.2 |
Net deferred tax asset |
0 |
0 |
0 |
0 |
| 19 |
Guaranty funds receivable or on deposit |
0 |
0 |
0 |
0 |
| 20 |
Electronic data processing equipment and software |
99,457,490 |
91,657,005 |
7,800,485 |
10,019,594 |
| 21 |
Furniture and equipment, including health care
delivery assets ($255) |
10,724,912 |
10,724,657 |
255 |
2,385 |
| 22 |
Net adjustment in assets and liabilities due to
foreign exchange rates |
0 |
0 |
0 |
0 |
| 23 |
Receivables from parent, subsidiaries and
affiliates |
6,479,296 |
0 |
6,479,296 |
2,585,642 |
| 24 |
Health care ($9226953) and other amounts
receivable |
18,527,279 |
2,086,387 |
16,440,892 |
15,377,989 |
| 25 |
Aggregate write-ins for other than invested
assets |
6,125,874 |
4,988,382 |
1,137,492 |
727,693 |
| 26 |
Total assets excluding Separate Accounts, Segregated
Accounts and Protected Cell Accounts |
916,275,785 |
122,387,947 |
793,887,838 |
801,143,505 |
| 27 |
From Separate Accounts, Segregated Accounts and
Protected Cell Accounts |
0 |
0 |
0 |
0 |
| 28 |
Totals |
916,275,785 |
122,387,947 |
793,887,838 |
801,143,505 |
|
Details of Write-Ins |
| 1101 |
Deposits |
2,843,524 |
0 |
2,843,524 |
3,335,999 |
| 1102 |
Investment in HPHC Institute |
11,609,062 |
11,609,062 |
0 |
0 |
| 1103 |
|
0 |
0 |
0 |
0 |
| 1104 |
|
0 |
0 |
0 |
0 |
| 1199 |
|
14,452,586 |
11,609,062 |
2,843,524 |
3,335,999 |
| 2501 |
Prepaid Expenses and Other Assets |
6,125,874 |
4,988,382 |
1,137,492 |
727,693 |
| 2502 |
|
0 |
0 |
0 |
0 |
| 2503 |
|
0 |
0 |
0 |
0 |
| 2504 |
|
0 |
0 |
0 |
0 |
| 2599 |
|
6,125,874 |
4,988,382 |
1,137,492 |
727,693 | |